10ACTIVITIES
1ORGS REPRESENTED
31BILLS
Organizations represented
1Orgs whose LD-2 filings list Anne as an active lobbyist, sorted by activity volume.
Bills they file on
31H.R. 71483 mentions
H.R. 52562 mentions
S. 33452 mentions
H.R. 66092 mentions
H.R. 19682 mentions
S. 8911 mention
S. 8821 mention
S. 9271 mention
H.R. 31641 mention
S. 24261 mention
H.R. 24281 mention
H.R. 43171 mention
H.R. 50311 mention
S. 31591 mention
S. 28001 mention
+ 16 more bills referenced in their activities
Topics in Filings
63Policy topics Anne files on across all their LD-2 activities.
340B ACCESS Act×2
PBM Price Transparency and Accountability Act×2
Pharmacists Fight Back in Medicare and Medicaid Act×2
Full-Year Continuing Appropriations and Extensions Act, 2025×2
H.Con.Res 14/S×2
Show all 63 topics (+58 more) ▾
Res. 7×2
Proposed Collection×2
Comment Request×2
Consolidated Appropriations Act×2
Controlled Substances Prescribing & Dispensing×1
Bipartisan Health Care Act×1
Patients Before Middlemen Act×1
Protecting Pharmacies in Medicaid Act×1
Comments to CMS on the implementation×1
P.L. 117-169×1
Long-Term Care Pharmacy at Home Services in Medicare×1
Comment Request [Docket No×1
PBM Reform×1
End-Stage Renal Disease Prospective Payment System×1
Calendar Year 2026 Home Health Prospective Payment System×1
Durable Medical Equipment×1
Orthotics, and Supplies×1
DMEPOS Accreditation Requirements×1
Provider Enrollment×1
CY 2026 Payment Policies×1
Medicare Shared Savings Program Requirements×1
Pharmacy and Medically Underserved Areas Enhancement Act×1
Grassley-Lujan Request-for-Information on Pharmacists Providing Chronic Care×1
CMMI Potential reimbursement model for CMS coverage of GLP-1 drugs×1
Consolidated Appropriations Act, 2026×1
Contract Year 2027 Policy×1
Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program×1
Delinking Revenue from Unfair Gouging Act×1
One Big Beautiful Bill×1
Compounding Animal Drugs From Bulk Drug Substances [Docket No×1
Comments to HHS/DOGE on government efficiency, fraud, waste and PBMs×1
Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients×1
Drug Shortage Compounding and Patient Access Act×1
Comments on the Risks and Benefits of Menopause Hormone Therapy×1
H.Res. 805×1
Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act×1
Lower Health Care Premiums for All Americans Act×1
Patient's Right to Know Their Medication Act×1
Fair Pharmacies for Federal Employees Act×1
Integrity and Reform×1
Rural Health Transformation Program×1
Creation and Implementation×1
Request for Information×1
Break up Big Medicine Act×1
Scientific and Clinical Considerations for Testosterone Replacement Therapy×1
Comments to DoL×1
Pharmacy Shortage Areas in reference to USC-NCPA joint project Mapping Tool×1
PBM Kickback Prohibition Act×1
Medication Guides for Prescription Drug Products [FDA-2025-N-6869]×1
Death Tax Repeal Act×1
Pharmacy Benefit Manager Transparency Act×1
Prescription Pricing for the People Act×1
TRICARE Pharmacy Network Oversight & Changes×1
National Defense Authorization Act×1
One Big Beautiful Bill Act×1
Departments of Labor×1
Internal Advice Letter H283420×1
Comments to the White House on the Corporate Transparency Act×1
Pulled from the org’s own LD-2 disclosures. See the source filings ↓
Issue mix
LDA general-issue codes weighted by activity count.
Alcohol and Drug Abuse1
Medicare/Medicaid1
Pharmacy1
Taxation/Internal Revenue Code1
Labor Issues/Antitrust/Workplace1
Defense1
Budget/Appropriations1
Telecommunications1
Trade (domestic/foreign)1
Small Business1